Strobe prevention in sickle cell disease (STOP): Baseline characteristics of trial patients.

被引：0
|
作者：
Adams, RJ
Brambilla, D
McKie, VC
Files, B
Vichinsky, E
Abboud, M
Hsu, L
Pegelow, C
Woods, G
Miller, S
Wang, W
Olivier, N
Berman, B
Hurlet, AJ
Driscoll, C
Scher, C
Wright, E
Gallagher, D
Carl, EM
Nichols, FT
Kutlar, A
Zimmerman, R
机构：
[1] MED COLL GEORGIA, AUGUSTA, GA 30912 USA
[2] NEW ENGLAND RES INST, WATERTOWN, MA 02172 USA
[3] CHILDRENS HOSP OAKLAND, OAKLAND, CA USA
[4] MED UNIV S CAROLINA, CHARLESTON, SC 29425 USA
[5] GRADY MEM HOSP, ATLANTA, GA 30303 USA
[6] CHILDRENS MERCY HOSP, KANSAS CITY, MO 64108 USA
[7] KINGS CTY HOSP, BROOKLYN, NY USA
[8] ST JUDE CHILDRENS RES HOSP, MEMPHIS, TN 38105 USA
[9] RAINBOW BABIES & CHILDRENS HOSP, CLEVELAND, OH 44106 USA
[10] CHILDRENS NATL MED CTR, WASHINGTON, DC 20010 USA
[11] CHILDRENS HOSP PHILADELPHIA, PHILADELPHIA, PA 19104 USA
来源：
BLOOD | 1997年 / 90卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：538 / 538
页数：1
相关论文
共 50 条
  • [1] Infections in sickle cell disease patients.
    Bégué, P
    [J]. PATHOLOGIE BIOLOGIE, 1999, 47 (01): : 19 - 25
  • [2] Stroke prevention in sickle cell disease (STOP): Follow up after closure of the trial.
    Adams, RJ
    Brambilla, D
    McKie, V
    Files, B
    Vichinsky, E
    Abboud, M
    Hsu, L
    Pegelow, C
    Woods, G
    Miller, S
    Wang, W
    Olivieri, N
    Berman, B
    Hurlet, A
    Piomelli, S
    Driscoll, C
    Scher, C
    Wright, E
    Zimmerman, R
    Carl, E
    Nichols, F
    Kutlar, A
    Roach, S
    Gallagher, D
    [J]. BLOOD, 1998, 92 (10) : 527A - 527A
  • [3] Stroke prevention in sickle cell disease (STOP): Final results
    Adams, RJ
    Brambilla, D
    McKie, V
    Files, B
    Vichinsky, E
    Abboud, M
    Hsu, L
    Pegelow, C
    Woods, G
    Miller, S
    Wang, W
    Olivieri, N
    Berman, B
    Hurlet, A
    Piomelli, S
    Driscoll, C
    Scher, C
    Adamkiewicz, T
    Wright, E
    Zimmerman, R
    Carl, E
    Nichols, F
    Kutlar, A
    Roach, S
    Granger, S
    Gallagher, D
    [J]. NEUROLOGY, 2002, 58 (07) : A258 - A259
  • [4] Baseline Characteristics of Patients with Sickle Cell Disease in An Ongoing 5-Year, Prospective, Noninterventional Registry Trial
    Heeney, Matthew M.
    Mueller, Brigitta U.
    Baltz, Brad
    Paley, Carole
    Esposito, Jason
    Sharma, Surabhi
    Vichinsky, Elliott
    [J]. BLOOD, 2011, 118 (21) : 488 - 489
  • [5] Prevalence of renal disease in sickle cell patients.
    Hasan, SP
    Anekwe, E
    Arora, M
    Sosanya, A
    Treakle-Moore, E
    [J]. BLOOD, 2003, 102 (11) : 23B - 23B
  • [6] Stroke prevention in sickle cell disease (STOP): Final results.
    Adams, R
    Brambilla, D
    McKie, V
    Files, B
    Vichinsky, E
    Abboud, M
    Hsu, L
    Pegelow, C
    Woods, G
    Miller, S
    Wang, W
    Olivieri, N
    Berman, B
    Hurlet, A
    Piomelli, S
    Driscoll, C
    Scher, C
    Adamkiewicz, T
    Wright, E
    Zimmerman, R
    Carl, E
    Nichols, F
    Kutlar, A
    Roach, S
    Granger, S
    Jones, A
    Gallagher, D
    [J]. BLOOD, 2000, 96 (11) : 10A - 10A
  • [7] Lessons from the stroke prevention trial in sickle cell anemia (STOP) study
    Adams, RJ
    [J]. JOURNAL OF CHILD NEUROLOGY, 2000, 15 (05) : 344 - 349
  • [8] Incidence of red cell antibodies in sickle cell disease patients.
    Calligas, TM
    Hawthorne, LM
    Garcia, A
    [J]. TRANSFUSION, 1998, 38 (10) : 35S - 35S
  • [9] Autoantibody formation and alloimmunization in sickle cell disease patients.
    Novaretti, MCZ
    Jens, E
    Pagliarini, T
    Rodrigues, AL
    Dorlhiac-Llacer, PE
    Chamone, DAF
    [J]. BLOOD, 2004, 104 (11) : 111B - 111B
  • [10] Gene expression profiling of sickle cell disease patients.
    Sun, CW
    Howard, TH
    Townes, TM
    [J]. BLOOD CELLS MOLECULES AND DISEASES, 2005, 34 (02) : 124 - 124
12345